Interferon antagonists encoded by SARS-CoV-2 at a glance

Med Microbiol Immunol. 2023 Apr;212(2):125-131. doi: 10.1007/s00430-022-00734-9. Epub 2022 Apr 2.

Abstract

The innate immune system is a powerful barrier against invading pathogens. Interferons (IFNs) are a major part of the cytokine-mediated anti-viral innate immune response. After recognition of a pathogen by immune sensors, signaling cascades are activated that culminate in the release of IFNs. These activate cells in an autocrine or paracrine fashion eventually setting cells in an anti-viral state via upregulation of hundreds of interferon-stimulated genes (ISGs). To evade the anti-viral effect of the IFN system, successful viruses like the pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolved strategies to counteract both IFN induction and signaling. In fact, more than half of the about 30 proteins encoded by SARS-CoV-2 target the IFN system at multiple levels to escape IFN-mediated restriction. Here, we review recent insights into the molecular mechanisms used by SARS-CoV-2 proteins to suppress IFN production and the establishment of an anti-viral state.

Keywords: COVID-19; Immune evasion; Innate immunity; Interferon; SARS-CoV-2.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • COVID-19*
  • Humans
  • Immunity, Innate
  • Interferons* / genetics
  • SARS-CoV-2

Substances

  • Interferons
  • Antiviral Agents